MedPath

Early induction of docetaxel for castration resistance prostate cancer

Phase 2
Recruiting
Conditions
prostate cancer
Registration Number
JPRN-UMIN000004072
Lead Sponsor
M-CURE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
65
Inclusion Criteria

Not provided

Exclusion Criteria

1)active infection 2)fever over 38 cent degree 3)allergy with docetaxel or steroid 4)physician deny the entry

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response of PSA level
Secondary Outcome Measures
NameTimeMethod
1)safeness 2)progression free survival 3) overall survival
© Copyright 2025. All Rights Reserved by MedPath